Precigen
@Precigen
Followers
931
Following
30
Media
216
Statuses
256
Precigen (Nasdaq: PGEN) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases
Germantown, MD
Joined January 2018
#Precigen is proud to announce the first and only @US_FDA-approved therapy for the treatment of adults with #RecurrentRespiratoryPapillomatosis. View press release: https://t.co/HfGaFVKhde
2
8
26
#Precigen to participate in upcoming virtual fireside chats hosted by Cantor and H.C. Wainwright to discuss the recent approval of the first and only FDA-approved therapy for the treatment of adults with RRP. View event details: https://t.co/xC07mMYbGB
0
2
7
NIH is thrilled to announce that the @US_FDA has granted full market approval for Papzimeos, a groundbreaking immunotherapy for adult patients with recurrent respiratory papillomatosis (RRP), a rare condition in which noncancerous growths develop in the air passages from the nose
16
25
134
Today, we approved a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent respiratory papillomatosis. https://t.co/ThwUZ3Swsc
27
22
85
Join us on Wednesday, September 18 for a fireside chat with @Precigen's President and CEO, Helen Sabzevari, at the 2024 Cantor Global Healthcare Conference. View details and register for the webcast: https://t.co/qia1jzRAvi
#CantorHCC
5
1
4
@Precigen reports second quarter / first half 2024 financial results and business updates. View press release and join our conference call today at 4:30pm ET: https://t.co/m2L0rdFZCO $PGEN
0
1
3
Join #Precigen on Wednesday, August 14, 2024 at 4:30 PM ET for a conference call to discuss second quarter and first half 2024 financial results. View details: https://t.co/qia1jzS8kQ $PGEN
0
2
4
#ICYMI: Watch the replay and check out photos from the first #RRPAwarenessDay. Thank you to our patient and caregiver panelists, our co-hosts at RRPF, @theNCI panelists, @MarkWarner, @iamwesmoore and all who viewed the event! https://t.co/TSVvJ2dttI
#GivingVoicetoInspireChange
1
2
6
We had an amazing time at our inaugural #RRPAwarenessDay. Together, we are shaping a hopeful and positive future for those impacted by RRP. Watch the #RRPAwarenessDay co-hosts share their thoughts on what they hope we achieved for RRP patients today. #GivingVoicetoInspireChange
0
2
7
Only 1 week to go until RRP Awareness Day, a multi-stakeholder event to raise awareness and bring together individuals living with RRP, caregivers, clinicians, and government officials. View details at https://t.co/1lf6FDYFaC and join us!
0
1
5
@Precigen is excited to announce pivotal study results for PRGN-2012 in RRP presented today in a late-breaking oral presentation at #ASCO24. Join us today for a live webcast with Precigen executives and study lead investigators. View data: https://t.co/O0wasRU6Sh
1
4
7
#ASCO24: On Monday, June 3, check out the trial-in-progress poster for @Precigen's PRGN-2009 AdenoVerse Gene Therapy in recurrent or metastatic cervical cancer (Abstract # TPS5623). https://t.co/dhNrF3cFiP
#GeneTherapy #Oncology #ClinicalTrials #CervicalCancer #OncoAlert
0
3
8
#ASCO24: On Sunday, June 2, check out the trial-in-progress poster for @Precigen's PRGN-2009 AdenoVerse Gene Therapy in HPV-associated oropharyngeal cancer (Abstract# TPS6124). https://t.co/0etKR7j0Km
#GeneTherapy #Oncology #ClinicalTrials #OncoAlert
1
3
6
#Precigen to host a webcast on June 3 at 6:00 PM CT following the late-breaking oral presentation of results from the pivotal study of PRGN-2012 for the treatment of RRP at #ASCO24. View details: https://t.co/qia1jzS8kQ $PGEN
1
1
8
Congratulations to #Precigen President and CEO, Helen Sabzevari, for being named as a PM360 Elite100 honoree in the Drug Researchers and Developers category. We are proud of her extraordinary leadership to advance innovative medicines. https://t.co/pATsx53t4V
2
0
7